Editors: Gene D. Morse, Sarah Nanzigu

Series Title: Frontiers in HIV Research

Advances in HIV Treatment: HIV Enzyme Inhibitors and Antiretroviral Therapy

Volume 1

eBook: US $39 Special Offer (PDF + Printed Copy): US $116
Printed Copy: US $96
Library License: US $156
ISSN: 2405-9862 (Print)
ISSN: 2405-9889 (Online)
ISBN: 978-1-68108-057-4 (Print)
ISBN: 978-1-68108-056-7 (Online)
Year of Publication: 2015
DOI: 10.2174/97816810805671150101

Introduction

Advances in HIV Treatment: HIV Enzyme Inhibitors and Antiretroviral Therapy presents comprehensive and updated information on drug therapies used to treat and manage HIV infection in human patients. The volume is organized in to chapters detailing respective classes of HIV Drugs including HIV entry inhibitors, reverse transcriptase inhibitors (RTIs), integrase strand inhibitors (INSTIs), and protease inhibitors (PIs). Each chapter compiles background information, pharmacology and clinical aspects such as side effects on the specific classes of drugs represented. Available data for ongoing research for new targets, including vaccines is also presented. Readers will also find a useful introduction to HIV virology and pathogenesis as well as a comparison of the availability and activity of these agents in different populations, opening a discussion on the influence of genetics and resources in curbing the HIV epidemic. Advances in HIV Treatment: HIV Enzyme Inhibitors and Antiretroviral Therapy is, therefore, a holistic resource for researchers, healthcare professionals and clinicians interested in understanding antiretroviral drugs and the management of HIV infection/AIDS. The volume is also of interest to undergraduate and graduate students undertaking specialized courses in pharmacology and HIV/AIDS management.

Foreword

- Pp. i
Charles Chiedza Maponga
Download Free

Preface

- Pp. ii
Gene D. Morse, Sarah Nanzigu
Download Free

List of Contributors

- Pp. iii
Gene D. Morse, Sarah Nanzigu
Download Free

Acknowledgements

- Pp. iv
Gene D. Morse, Sarah Nanzigu
Download Free

Introduction

- Pp. 3-22 (20)
Sarah Nanzigu, Francis Xavier Kasujja, Immaculate Nankya

PDF Price: $15

View Abstract Purchase Chapter

HIV-1 Entry Inhibitors

- Pp. 23-43 (21)
Joshua R. Sawyer, Charles S. Venuto, Gene D. Morse

PDF Price: $15

View Abstract Purchase Chapter

Reverse Transcriptase Inhibitors

- Pp. 44-61 (18)
Amy Moss, Cara Felton, Sarah Nanzigu

PDF Price: $15

View Abstract Purchase Chapter

Integrase Inhibitors

- Pp. 62-74 (13)
Sarah Nanzigu, Francis Xavier Kasujja

PDF Price: $15

View Abstract Purchase Chapter

Protease Enzyme Inhibition

- Pp. 75-96 (22)
Rebecca A. Sumner, Cindy J. Bednasz, Qing Ma, Gene D. Morse

PDF Price: $15

View Abstract Purchase Chapter

Pharmacogenomics and Antiretroviral Therapy: Pharmacogenomics of HIV-1 Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors - Implications for Personalized Antiretroviral Therapy

- Pp. 97-114 (18)
Qing Ma, Kevin Hsu, Gene D. Morse

PDF Price: $15

View Abstract Purchase Chapter

HIV Co-Treatment

- Pp. 115-135 (21)
Sarah Nanzigu, Jaran Eriksen, Pauline Byakika-Kibwika

PDF Price: $15

View Abstract Purchase Chapter

Demographic Influence on the Evolution of Antiretroviral Therapy (ART)

- Pp. 136-153 (18)
Sarah Nanzigu, Moses R. Kamya, Gene D. Morse

PDF Price: $15

View Abstract Purchase Chapter

Subject Index

- Pp. 154-160 (7)
Gene D. Morse, Sarah Nanzigu
Download Free

RELATED BOOKS

.Frontiers in Clinical Drug Research - Anti Infectives- Vol 9.
.COVID-19: Causes, Transmission, Diagnosis, and Treatment.
.Emerging Approaches to Tackle Neglected Diseases: From Molecule to End Product.
.COVID 19 – Monitoring with IoT Devices.